Abstract:Background Currently, over 90 genetic loci have been found to be associated with Parkinson’s disease (PD) in genome-wide association studies, nevertheless, the effects of these genetic variants on the clinical features and brain structure of PD patients are largely unknown. Objective This study investigated the effects of microtubule-associated protein tau ( MAPT ), rs17649553 (C>T), a genetic variant associated with reduced PD risk, on the functional and structural networks of PD patients. Methods Totally 83 PD subjects from Parkinson’s Progression Markers Initiative database were included for this study. They all received structural and functional magnetic resonance imaging and whole exome sequencing. The effects of MAPT rs17649553 on brain structural and functional networks were systematically assessed. Results MAPT rs17649553 T allele was associated with better verbal memory in PD patients. In addition, MAPT rs17649553 significantly reshaped the topology of gray matter covariance network and white matter network but not that of functional network. Both the network metrics in gray matter covariance network and white matter network were correlated with verbal memory, however, the mediation analysis showed that it was the small-worldness topology in white matter network that mediated the effects of MAPT rs17649553 on verbal memory. Conclusion In sum, we proposed that MAPT rs17649553 T allele was associated with superior structural network topology and better verbal memory in PD. Future studies are needed to determine the role of MAPT rs17649553 in PD initiation and progression. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from the National Key Research and Development Program (2016YFC1306505) and the National Natural Science Foundation of China (81471287, 81071024, 81171202). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: [www.ppmiinfo.org][1] I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors <http://www.ppmi-info.org/data> [1]: https://www.ppmiinfo.org

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

MAPT As a Predisposing Gene for Sporadic Amyotrophic Lateral Sclerosis in the Chinese Han Population.

The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy

Further validation of the association between MAPT haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and APOE genotype

Variants in the SNCA Gene Associate with Motor Progression While Variants in the MAPT Gene Associate with the Severity of Parkinson's Disease.

Genome-wide Association Study Identifies MAPT Locus Influencing Human Plasma Tau Levels.

Association analysis of MAPK1 gene and Alzheimer's disease in Han Chinese

MAPT Rs242557 Variant is Associated with Hippocampus Tau Uptake on 18F-AV-1451 PET in Non-Demented Elders.

Effects of<i>MAPT</i>rs17649553 on Structural Network Integrity and Verbal Memory in Parkinson’s Disease

MAPT rs17649553 T allele is associated with better verbal memory and higher small-world properties in Parkinson's disease

A Genomic Sequence Analysis of the Mouse and Human Microtubule-Associated Protein Tau.

Association Between MAPT Haplotype and Memory Function in Patients with Parkinson's Disease and Healthy Aging Individuals.

An Exploratory Study on STX 6 , MOBP , MAPT , and EIF 2 AK 3 and Late-Onset Alzheimer ’ S Disease

Association Of The Tauopathy Gwas Loci With Alzheimer'S Disease In China

Association Analysis of the Grn Rs5848 and Mapt Rs242557 Polymorphisms in Parkinson'S Disease and Multiple System Atrophy: A Large-Scale Population-Based Study and Meta-Analysis

Association Analysis of GSK3B and MAPT Polymorphisms with Alzheimer's Disease in Han Chinese

A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy

Full Sequencing and Haplotype Analysis of MAPT in Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder

Polymorphism of neurodegeneration-related genes associated with Parkinson's disease risk

Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements

Effects of MAPT rs17649553 on Structural Network Integrity and Verbal Memory in Parkinson’s Disease